CTSI Update: Reminder
Research to Reality:
Human-Centered Approaches to Recruitment and Retention

Presented by Lisa Marceau, MPH, PMP & Julia Coleman, BA [Anthem/HealthCore (formerly NERI)] 

The goal of this series is to provide an understanding of the ethical background,
regulatory knowledge, and models of best practices for conducting research when the participants represent special populations and vulnerable subjects. 
New Funding Opportunities

Application Deadline: Jun. 16, 2021

RWJF's new Health Equity Scholars for Action program provides support to help you thrive professionally and personally, and contribute to evidence that can help build a Culture of Health. Grants, up to $250,000 each, are available for research projects about health, well-being, and equity; the award includes mentorship and coaching as well as a community of support to help build your network and develop career opportunities.

Application Deadline: Jun. 29, 2021
Award Ceiling: $500,000
Award Floor: $300,000
Estimated Total: $2,000,000
This notice solicits applications
for projects to demonstrate the effectiveness of interventions for increasing minority participation in lupus-related clinical trials to help reduce lupus-related health disparities experienced by racial
and ethnic minority populations.

Application Deadline: May 15, 2021

The Initiative is designed to accelerate the development of clinician-inspired medical device innovations by partnering with a team with expertise in engineering design and product development.

The solicited research will improve understanding of and develop strategies to prevent and treat post-acute manifestations of SARS-CoV-2 infection across the lifespan
News Highlights
How Severe COVID-19 Can Tragically Lead to Lung Failure and Death

Though progress has been made in a little more than a year to develop effective vaccines, diagnostic tests, and treatments, there’s still much we don’t know about what precisely happens in the lungs and other parts of the body that leads to lethal outcomes. Read More
A Real-World Look at COVID-19 Vaccines Versus New Variants

Clinical trials have shown the COVID-19 vaccines now being administered around the country are highly effective in protecting fully vaccinated individuals from the coronavirus SARS-CoV-2. But will they continue to offer sufficient protection? Read More
Another Published Preprint from the National COVID Cohort Collaborative (N3C)

The findings from this research support the hypothesis that stimulation of active compounds against SARS-CoV-2 proteins followed by statistical analysis of electronic health data results in effective therapeutics identification.  Read More
Drug Repositioning Candidates Identified Using in-Silico Quasi-Quantum Molecular Simulation Demonstrate Reduced COVID-19 Mortality in 1.5M Patient Records

Drug repositioning is a key component of COVID-19 pandemic response, through the identification of existing drugs that can effectively disrupt COVID-19 disease processes. Read More
Long-Lasting Medications May Improve Treatment Satisfaction in People with Opioid Use Disorder

Medications used to treat opioid use disorder are highly effective. However, retention rates for these drugs are quite low, and 40% to 50% of patients treated with methadone or buprenorphine relapse within six months of starting treatment. Read More
Upcoming Events
Opportunities and Challenges of Harnessing the Power of Data to Advance Immune-Mediated and Infectious Disease Research
May. 14, 2021, 2 - 3:30 p.m.

Transdisciplinary collaboration is critical to harnessing the power of data so that it can be used to rapidly transform the research landscape and advance science. Read More
Un-Meeting: Exploring the Inclusion of Community Hospitals in Clinical Research
May. 27, 2021, 11 a.m. - 3 p.m.

This NCATS “Rapid-Response” Un-Meeting will encourage discussions to identify activities that can be initiated and sustained in the interpandemic period to include when a significant public health emergency arises in the future. Read More
Summit on Anti-SARS-CoV-2 Antibodies for Treatment and Prevention of COVID-19
Jun. 15, 2021, 11 a.m.

Lessons learned on clinically relevant anti-SARS-CoV-2 antibodies (Abs) for the treatment and/or prevention of COVID-19 and to identify key unanswered scientific questions to catalyze Ab clinical development and implementation. . Read More
2nd Lecture in ORWH’s COVID-19 Speaker Series Will Consider Applications of Intersectionality
Jun. 24, 2021, 1-2 p.m.
The series aims to disseminate key COVID-19 research findings that are relevant to diverse groups of women and incorporate a multidimensional sex-and-gender focus.
Funding Acknowledgement
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.